]>Tree-Based Methods for Discovery of Association between Flow Cytometry Data and Clinical Endpoints : Table 2
Table 2: Univariate associations with CD4+ count at 36 weeks on ART.
Predictor Odds ratioP-value
CD3-DR-CD56+CD16+ 0.183 .008
Lin-DR- 0.228 .018
CD45+CD3+ 0.274 .035
CD3+CD8+CD38+CD28+ 0.281 .047
CD3-CD8+ 0.323 .084
CD3-DR+CD56+CD16+ 0.339 .087
CD3+CD8-CD7+CD154+ 0.339 .087
CD3-DR-CD56-CD16- 0.364 .113
CD3+CD8+CD7+CD154+ 0.388 .463
CD3+CD8-CD7+CD154- 0.389 .146
CD3+CD8-DR+CD95- 0.429 .189
CD3+DR- 0.460 .236
CD3+CD8-CD45RA+CD62L+ 0.477 .283
CD3+CD8-DR+CD95+ 0.477 .283
CD45-CD3+ 0.494 .632
CD3+CD8- 0.494 .632
Lin-DR+CD123+CD11c+ 0.564 .424
CD3+CD8+DR+CD95+ 0.628 .571
CD3-DR+ 0.646 .586
CD3+CD8-DR-CD95- 0.646 .586
CD45+CD3+CD8-CD4- 0.703 .690
CD3+CD8+CD38-CD28+ 0.709 .699
CD3+CD8-CD7-CD154- 0.740 .774
CD3+CD8+ 0.752 .786
CD3+CD8-CD38+CD28+ 0.759 .797
CD3+CD8+CD38+CD28- 0.760 .812
CD3-DR+CD56-CD16- 0.805 .887
CD3-DR+CD56+CD16- 0.805 .887
CD3+CD8+CD38-CD28- 0.813 .898
CD45-CD3- 0.862 .989
Lin-DR+CD123+CD11c- 0.913 .917
CD3+CD8+CD45RA+CD62L- 0.923 .908
CD3+CD8+CD45RA-CD62L 0.931 .898
CD45+CD3+CD8-CD4+ 0.931 .898
CD3+CD8+DR+CD95- 0.938 .887
CD3+CD8-CD7-CD154+ 0.962 .696
CD3+CD8-CD38+CD28- 0.996 .797
CD3+CD8+DR-CD95- 1.004 .797
Lin+DR+ 1.074 .898
CD3-DR-CD56-CD16+ 1.074 .898
CD3-CD8- 1.074 .898
Lin+DR- 1.149 1.000
CD45+CD3- 1.160 .989
CD3+CD8-CD38-CD28- 1.160 .989
CD3+CD8-CD45RA+CD62L- 1.230 .898
CD45+CD3+CD8+CD4- 1.317 .797
CD3+DR+ 1.329 .786
Lin-DR+CD123-CD11c- 1.329 .786
CD3+CD8-DR-CD95+ 1.329 .786
CD3+CD8+DR-CD95+ 1.410 .699
CD45+CD3+CD8+CD4+ 1.410 .699
CD3+CD8+CD45RA-CD62L+ 1.422 .690
CD3-DR- 1.446 .677
CD3-DR+CD56-CD16+ 1.486 .661
Lin-DR+ 1.511 .605
CD4+ 1.522 .598
Lin-DR+CD123-CD11c+ 1.522 .598
CD3+CD8-CD45RA-CD62L+ 1.630 .512
CD3-DR-CD56+CD16- 1.630 .512
CD3+CD8+CD7+CD154- 1.657 .502
CD3+CD8+CD7-CD154- 1.707 .487
CD3+CD8-CD38-CD28+ 1.898 .354
CD3+CD8-CD45RA-CD62L 2.011 .294
CD3+CD8+CD45RA+CD62L+ 2.152 .238